Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Parallel Group, Placebo Controlled, Multi Center Dose Ranging Study of Solifenacin Succinate in Combination With Tamsulosin Hydrochloride Compared With Solifenacin Succinate Monotherapy and Tamsulosin Hydrochloride Monotherapy in Males With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH)
Brief Summary: The study will examine the efficacy,safety and tolerability of combination therapy of tamsulosin and solifenacin compared to placebo and monotherapy of tamsulosin and solifenacin in the treatment of males with LUTS associated with BPH.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo tamsulosin hydrochloride OCAS 0.4 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg | Arm Label: TOCAS 0.4 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg, Drug: tamsulosin hydrochloride OCAS 0.4 mg | Arm Label: FDC 0.4 mg/6 mg; Type: EXPERIMENTAL; Interventions: Drug: Placebo tamsulosin hydrochloride OCAS 0.4 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg, Drug: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg) | Arm Label: FDC 0.4 mg/9 mg; Type: EXPERIMENTAL; Interventions: Drug: Placebo tamsulosin hydrochloride OCAS 0.4 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg, Drug: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg) | Intervention Type: DRUG; Name: Placebo tamsulosin hydrochloride OCAS 0.4 mg; Assigned to Arm(s): FDC 0.4 mg/6 mg, FDC 0.4 mg/9 mg, Placebo | Intervention Type: DRUG; Name: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg; Assigned to Arm(s): FDC 0.4 mg/9 mg, Placebo, TOCAS 0.4 mg | Intervention Type: DRUG; Name: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg; Assigned to Arm(s): FDC 0.4 mg/6 mg, Placebo, TOCAS 0.4 mg | Intervention Type: DRUG; Name: tamsulosin hydrochloride OCAS 0.4 mg; Assigned to Arm(s): TOCAS 0.4 mg | Intervention Type: DRUG; Name: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg); Assigned to Arm(s): FDC 0.4 mg/6 mg | Intervention Type: DRUG; Name: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg); Assigned to Arm(s): FDC 0.4 mg/9 mg
B: Arm Label: A; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: solifenacin succinate | Arm Label: C; Type: ACTIVE_COMPARATOR; Interventions: Drug: solifenacin succinate | Arm Label: D; Type: ACTIVE_COMPARATOR; Interventions: Drug: solifenacin succinate | Arm Label: E; Type: ACTIVE_COMPARATOR; Interventions: Drug: tamsulosin hydrochloride | Arm Label: F; Type: ACTIVE_COMPARATOR; Interventions: Drug: tamsulosin hydrochloride, Drug: solifenacin succinate | Arm Label: G; Type: ACTIVE_COMPARATOR; Interventions: Drug: tamsulosin hydrochloride, Drug: solifenacin succinate | Arm Label: H; Type: ACTIVE_COMPARATOR; Interventions: Drug: tamsulosin hydrochloride, Drug: solifenacin succinate | Intervention Type: DRUG; Name: tamsulosin hydrochloride; Assigned to Arm(s): E, F, G, H | Intervention Type: DRUG; Name: solifenacin succinate; Assigned to Arm(s): B, C, D, F, G, H | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): A
C: Intervention Type: DRUG; Name: Detrol LA; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: Tolterodine ER 4 mg QD; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Tamsulosin 0.4 mg QD; Assigned to Arm(s): N/A

Answer: B